How To Navigate The Life Sciences Funding LandscapeAmy Cotterill2024-11-28T14:03:27+00:00November 6th, 2023|Article, Investment|
Pioneer Group Announces Participation In £2m Investment In 3D Drug Development Innovator ImmuONESteve Jarvis2024-11-28T14:31:19+00:00October 26th, 2023|Investment, News|
Pioneer Group Announces Investment In Bastion TherapeuticsSteve Jarvis2024-11-28T14:33:10+00:00September 12th, 2023|Investment, News|
Intelligent OMICS Ltd In AI-Driven Research Collaboration With JanssenSteve Jarvis2024-11-28T14:33:26+00:00September 7th, 2023|Investment, News|
Pioneer Group Welcomes Horizon DealSteve Jarvis2023-09-08T09:23:24+01:00September 7th, 2023|Investment, News|
How To Scale A Start-Up: A Guide For Early-Stage Life Science BusinessesAmy Cotterill2024-11-28T14:05:06+00:00August 15th, 2023|Accelerator, Article, Investment|
How Creative Incubation Supports Life Sciences In The UKSteve Jarvis2024-11-28T14:38:23+00:00July 13th, 2023|Accelerator, BioCity Glasgow, Investment, News|
Commercializing The Success Of Scottish Life Sciences Will Rely On Scale-Up Space And Government DirectionSteve Jarvis2024-11-28T14:19:20+00:00June 14th, 2023|Article, BioCity Glasgow, Edinburgh Technopole, Investment|
Pioneer Group Appointed Delivery Partner For Innovate UK’s Biomedical Catalyst Accelerator ProgrammeAmy Cotterill2024-11-28T14:45:08+00:00May 10th, 2023|Accelerator, News|
Pioneer Group Adds NunaBio To Venture Building ProgrammeSteve Jarvis2024-11-28T14:45:20+00:00April 21st, 2023|Investment, News|
